Is TB-500 FDA Approved? The 2026 Regulatory Status, Explained

Q: Is TB-500 FDA approved?

No. TB-500 is not an FDA-approved drug. It is a synthetic peptide related to thymosin beta-4 and is supplied strictly as a research-use-only compound. It is listed for discussion at the FDA's July 2026 compounding advisory committee meeting, but that review of possible 503A Bulks List inclusion is not the same as drug approval.

Q: Is TB-500 the same as thymosin beta-4?

They are closely related but not identical. TB-500 is a synthetic peptide associated with the active region of the naturally occurring protein thymosin beta-4, and the two names are often used interchangeably in research discussion. Neither is an FDA-approved medicine.

Q: Is TB-500 banned in sport?

Yes. The World Anti-Doping Agency (WADA) prohibits TB-500 (and thymosin beta-4) at all times. Athletes in tested sport can face sanctions for its use, regardless of the compound's research-use status.

Short answer: no. TB-500 is not an FDA-approved drug. It is a synthetic peptide related to thymosin beta-4, supplied strictly as a research-use-only compound. TB-500 is on the FDA’s July 23, 2026 compounding advisory committee agenda (evaluated use: wound healing) — a review of possible 503A Bulks List inclusion, which is not drug approval. It is also prohibited in tested sport by WADA.

Like its frequent companion BPC-157, TB-500 is widely discussed in recovery and tissue-repair circles — and just as often misunderstood when it comes to its regulatory status. The short answer to “is TB-500 FDA approved?” is no. Here is the fuller picture, including the July 2026 FDA review and the sport-doping angle.

What “FDA approved” actually means

FDA approval requires a sponsor to submit a New Drug Application backed by Phase I–III clinical trials, manufacturing controls and a characterised safety profile, after which the FDA decides whether the drug is safe and effective for a specific indication. TB-500 has not been through that process — there is no approved application and no completed Phase III programme. For the compounds that have cleared that bar, see our FDA peptide approval pipeline guide.

Is TB-500 FDA approved? The current status

No. TB-500 is a synthetic peptide associated with the active region of thymosin beta-4 , a naturally occurring protein studied in cellular-migration, angiogenesis and wound-healing research. The two names are often used interchangeably in research discussion, though they are not strictly identical. As of 2026, TB-500 remains a research compound : supplied to laboratories as a reagent, labelled research use only.

The usual confusion. “Not FDA approved” does not mean “banned” or “illegal to study.” It means TB-500 has not been authorised as a medicine for human use. Research-grade material is a separate category, and the legal line follows marketing and use, not the molecule alone.

The July 2026 FDA review: still not approval

On July 23, 2026, the FDA’s Pharmacy Compounding Advisory Committee is scheduled to discuss TB-500 bulk drug substances (free base and acetate), with wound healing listed as the evaluated use, as part of a review of several peptide-related substances for potential 503A Bulks List inclusion. The 503A list relates to traditional pharmacy compounding — not mass-market drug approval. A recommendation for inclusion would not make TB-500 an FDA-approved medicine. We cover the regenerative angle in detail in our BPC-157 and TB-500 FDA review.

Is TB-500 banned in sport?

Yes. The World Anti-Doping Agency (WADA) prohibits TB-500 and thymosin beta-4 at all times. Any athlete in a tested sport who uses it risks an anti-doping violation, independent of the compound’s research-use status. If you compete under WADA or a national anti-doping code, treat TB-500 as prohibited. (BPC-157 carries the same WADA prohibition — see Is BPC-157 banned?)

Why TB-500 isn’t approved

As with BPC-157, most of the TB-500 / thymosin beta-4 evidence base is pre-clinical rather than the large, controlled human trials approval demands. It is also a peptide with limited commercial-trial sponsorship, and regulators have raised characterisation and safety-data questions. That reflects where the formal evidence process stands, not a verdict on the underlying biology.

What this means if you research TB-500

Because TB-500 is not approved, responsible suppliers position it for research use only and back it with batch-specific testing. Look for a Certificate of Analysis confirming identity and purity, and treat any “FDA-approved TB-500” claim as a red flag — no such approval exists.

Frequently Asked Questions

Is TB-500 FDA approved? No. It is not an FDA-approved drug; it is a research-use-only peptide related to thymosin beta-4.

Is TB-500 the same as thymosin beta-4? Closely related and often used interchangeably, but not strictly identical. Neither is FDA approved.

Is TB-500 banned in sport? Yes — WADA prohibits TB-500 and thymosin beta-4 at all times for tested athletes.

Buy TB-500 from New-U Research Compounds

Lab-verified by Janoshik Analytical (RP-HPLC + ESI-MS), sealed vials, discreet tracked worldwide shipping. Research use only - all claims made on this site are for testing and research use only.

PRECISION. PURITY. PERFORMANCE.

Research peptides. Third-party Certificates of Analysis (Janoshik Analytical & Freedom Diagnostics) are published on the website. Supplied strictly for laboratory research use.

Shop

All research compounds

Price list

Where to buy peptides

Research